13F-HR: Walgreens Boots Alliance Discloses Significant Equity Holdings in Latest 13F Filing
13F Holdings Report
Walgreens Boots Alliance's latest 13F filing reveals substantial equity positions in BrightSpring Health Services and Cencora, Inc.
Summary
- Walgreens Boots Alliance, Inc. filed its 13F holdings report for the quarter ending September 30, 2024.
- The filing discloses holdings in two companies: BrightSpring Health Services and Cencora, Inc.
- The total value of the reported holdings is approximately $4,838,261,541.
- Walgreens Boots Alliance holds 23,239,996 shares of BrightSpring Health Services, valued at $341,163,141.
- They also hold 19,980,000 shares of Cencora, Inc., valued at $4,497,098,400.
- The report includes three other investment managers: Walgreen Co., WBA Investments, Inc., and Walgreens Boots Alliance Holdings LLC.
Sentiment
Score: 7
Explanation: The document is a routine filing, but the large holdings suggest a positive outlook on the companies invested in. The sentiment is neutral to slightly positive.
Positives
- The filing provides transparency into Walgreens Boots Alliance's significant investment positions.
- The large holdings in Cencora, Inc. suggest a strong strategic alignment or confidence in the company.
Risks
- The value of these holdings is subject to market fluctuations and the performance of the underlying companies.
- Changes in the healthcare or pharmaceutical industries could impact the value of these investments.
Management Comments
- Joseph B. Amsbary, Jr., Senior Vice President and Corporate Secretary, signed the report on behalf of Walgreens Boots Alliance.
Industry Context
This filing reflects the investment strategy of a major player in the healthcare and pharmaceutical sectors, showing their significant stakes in companies within their industry ecosystem.
Comparison to Industry Standards
- Large institutional investors like Walgreens Boots Alliance often hold significant positions in publicly traded companies within their sector.
- The size of the holdings in Cencora, Inc. is substantial, indicating a major strategic investment or a long-term partnership.
- Other large pharmaceutical and healthcare companies also file 13F reports, which can be compared to understand industry-wide investment trends.
Stakeholder Impact
- Shareholders of Walgreens Boots Alliance can gain insight into the company's investment strategy.
- The holdings may impact the share prices of BrightSpring Health Services and Cencora, Inc.
Key Dates
| Date | Description |
|---|---|
| 09-30-2024 | End of the calendar quarter for which the 13F report is filed. |
| 11-14-2024 | Date the 13F report was signed and submitted. |
Keywords
13F Filing, Walgreens Boots Alliance, BrightSpring Health Services, Cencora, Inc., Equity Holdings, Institutional Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.